v3.26.1
Additional Information - Condensed Financial Statements of the Company (Tables)
12 Months Ended
Dec. 31, 2025
Condensed Financial Information Disclosure [Abstract]  
Condensed financial information of the company, balance sheets

 

 

As of December 31,

 

 

 

2024

 

 

2025

 

 

 

RMB

 

 

RMB

 

ASSETS

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

Cash and cash equivalents

 

 

480

 

 

 

559

 

Amounts due from subsidiaries and VIEs

 

 

962,552

 

 

 

942,892

 

Prepayments and other current assets

 

 

3,609

 

 

 

3,204

 

Total current assets

 

 

966,641

 

 

 

946,655

 

Non-current assets:

 

 

 

 

 

 

Investments in the subsidiaries

 

 

488,251

 

 

 

500,416

 

Available-for-sale debt investments

 

 

313

 

 

 

306

 

Total non-current assets

 

 

488,564

 

 

 

500,722

 

Total assets

 

 

1,455,205

 

 

 

1,447,377

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current liabilities:

 

 

 

 

 

 

Amounts due to subsidiaries and VIEs

 

 

278,913

 

 

 

275,349

 

Accrued expenses and other current liabilities

 

 

1,025

 

 

 

885

 

Total current liabilities

 

 

279,938

 

 

 

276,234

 

Total liabilities

 

 

279,938

 

 

 

276,234

 

Shareholders’ equity:

 

 

 

 

 

 

Class A ordinary shares (US$0.01 par value, 680,000,000 shares authorized; 264,998,965 shares issued and 259,191,877 shares outstanding as of December 31, 2024 and 2025, respectively)

 

 

17,499

 

 

 

17,499

 

Class B ordinary shares (US$0.01 par value, 320,000,000 shares authorized; 317,325,360 shares issued and 317,325,360 shares outstanding as of December 31, 2024 and 2025, respectively)

 

 

22,053

 

 

 

22,053

 

Additional paid-in capital

 

 

1,642,077

 

 

 

1,642,094

 

Treasury stock (5,807,088 shares as of December 31, 2024 and 2025, respectively)

 

 

(1,480

)

 

 

(1,480

)

Accumulated deficits

 

 

(467,577

)

 

 

(467,241

)

Accumulated other comprehensive loss

 

 

(37,305

)

 

 

(41,782

)

Total shareholders’ equity

 

 

1,175,267

 

 

 

1,171,143

 

Total liabilities and shareholders’ equity

 

 

1,455,205

 

 

 

1,447,377

 

Condensed financial information of the company, statements of comprehensive income/(loss)

 

 

For the Years Ended December 31,

 

 

 

2023

 

 

2024

 

 

2025

 

 

 

RMB

 

 

RMB

 

 

RMB

 

Operating expenses:

 

 

 

 

 

 

 

 

 

General and administrative expenses

 

 

(16,902

)

 

 

(8,979

)

 

 

(6,562

)

Total operating expenses

 

 

(16,902

)

 

 

(8,979

)

 

 

(6,562

)

Loss from operations

 

 

(16,902

)

 

 

(8,979

)

 

 

(6,562

)

Other income/(loss):

 

 

 

 

 

 

 

 

 

Net interest income

 

 

944

 

 

 

1,072

 

 

 

2

 

Foreign currency exchange (loss)/gain

 

 

(4,181

)

 

 

(3,628

)

 

 

5,482

 

Share of (loss)/income from the subsidiaries

 

 

(82,357

)

 

 

(42,019

)

 

 

1,414

 

Net (loss)/income

 

 

(102,496

)

 

 

(53,554

)

 

 

336

 

Other comprehensive income/(loss)

 

 

5,005

 

 

 

3,092

 

 

 

(4,477

)

Comprehensive loss

 

 

(97,491

)

 

 

(50,462

)

 

 

(4,141

)

 

Condensed financial information of the company, statements of cash flows

 

 

For the Years Ended December 31,

 

 

 

2023

 

 

2024

 

 

2025

 

 

 

RMB

 

 

RMB

 

 

RMB

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

 

Net cash used in operating activities

 

 

(20,850

)

 

 

(4,497

)

 

 

(6,364

)

Cash flows from investing activities:

 

 

 

 

 

 

 

 

 

Placement of short-term investments

 

 

(58,951

)

 

 

(108,928

)

 

 

—

 

Maturity of short-term investments

 

 

61,388

 

 

 

108,928

 

 

 

—

 

Return of equity investment principal from a subsidiary

 

 

19,722

 

 

 

—

 

 

 

—

 

Net cash provided by investing activities

 

 

22,159

 

 

 

—

 

 

 

—

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

 

Repayment from/(payment to) subsidiaries and VIEs

 

 

10,332

 

 

 

(15,736

)

 

 

6,443

 

Repurchase of ordinary shares

 

 

(655

)

 

 

(825

)

 

 

—

 

Net cash provided by/(used in) financing activities

 

 

9,677

 

 

 

(16,561

)

 

 

6,443

 

Net increase/(decrease) in cash and cash equivalents

 

 

10,986

 

 

 

(21,058

)

 

 

79

 

Cash and cash equivalents at the beginning of the year

 

 

10,552

 

 

 

21,538

 

 

 

480

 

Cash and cash equivalents at the end of the year

 

 

21,538

 

 

 

480

 

 

 

559